Immediate Impact
53 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Works of Caroline Behler being referenced
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
2018
Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Caroline Behler | 185 | 33 | 289 | 195 | 16 | 397 | |
| Gaurav Varma | 181 | 29 | 330 | 167 | 16 | 418 | |
| Taoufik El Gnaoui | 223 | 12 | 336 | 134 | 17 | 383 | |
| Lilj Uziel | 133 | 28 | 243 | 127 | 12 | 349 | |
| Maya Hacini | 185 | 45 | 272 | 78 | 15 | 344 | |
| Eva Berra | 196 | 23 | 262 | 57 | 14 | 369 | |
| Federica Quirini | 176 | 32 | 365 | 78 | 17 | 423 | |
| F. Le Marcʼhadour | 132 | 26 | 196 | 50 | 18 | 336 | |
| Renato Scalone | 150 | 121 | 242 | 91 | 16 | 446 | |
| Antonella Ferrari | 98 | 57 | 188 | 114 | 18 | 347 | |
| Lenka Šmardová | 210 | 26 | 245 | 118 | 23 | 384 |
All Works
Loading papers...